Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma (Q44707208)

5 December 2017

Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma (English)

1 reference

5 December 2017

8

1 reference

5 December 2017

Rong Bu

1

1 reference

5 December 2017

Prashant Bavi

2

1 reference

5 December 2017

Jehad Abubaker

3

1 reference

5 December 2017

Zeenath Jehan

4

1 reference

5 December 2017

Wael Al-Haqawi

5

1 reference

5 December 2017

Dahish Ajarim

6

1 reference

5 December 2017

Fouad Al-Dayel

7

1 reference

5 December 2017

Khawla S Al-Kuraya

9

1 reference

5 December 2017

18 April 2012

1 reference

5 December 2017

1 reference

5 December 2017

53

1 reference

5 December 2017

10

1 reference

5 December 2017

1971-1977

1 reference

Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach

5 December 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

The biology of human lymphoid malignancies revealed by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Nuclear factor kB as a target for new drug development in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Current insights into the regulation of programmed cell death by NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Dying for NF-kappaB? Control of cell death by transcriptional regulation of the apoptotic machinery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

A requirement for CARMA1 in TCR-induced NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

A20: central gatekeeper in inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Frequent inactivation of A20 in B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Potential role of CARMA1 in CD40-induced splenic B cell proliferation and marginal zone B cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Analysis of CARMA1/BCL10/MALT1 expression in Reed-Sternberg cells of classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

CARMA1 is required for Akt-mediated NF-kappaB activation in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.668286

10.3109/10428194.2012.668286

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference